![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 487/04 | |
C07D 519/00 |
(11) | Number of the document | 2867236 |
(13) | Kind of document | T |
(96) | European patent application number | 13752678.6 |
Date of filing the European patent application | 2013-06-19 | |
(97) | Date of publication of the European application | 2015-05-06 |
(45) | Date of publication and mention of the grant of the patent | 2017-06-14 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2013/055039 |
Date | 2013-06-19 |
(87) | Number | WO 2014/001973 |
Date | 2014-01-03 |
(30) | Number | Date | Country code |
201261666299 P | 2012-06-29 | US | |
201361820828 P | 2013-05-08 | US |
(72) |
GALATSIS, Paul, US
HAYWARD, Matthew Merrill, US
HENDERSON, Jaclyn, US
KORMOS, Bethany Lyn, US
KURUMBAIL, Ravi G, US
STEPAN, Antonia Friederike, US
VERHOEST, Patrick Robert, US
WAGER, Travis T., US
ZHANG, Lei, US
|
(73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
(54) | NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-D]PYRIMIDINES AS LRRK2 INHIBITORS |
NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-D]PYRIMIDINES AS LRRK2 INHIBITORS |